PNC Financial Services Group
TLSI icon

PNC Financial Services Group’s TriSalus Life Sciences TLSI Stock Holding History

PNC Financial Services Group’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$651 Buy
143
+108
+309% +$429 ﹤0.01% 4928
2026
Q1 		$140 Buy
35
+13
+59% +$64 ﹤0.01% 5073
2025
Q4 		$154 Sell
22
-43
-66% -$241 ﹤0.01% 5012
2025
Q3 		$302 Buy
+65
New +$304 ﹤0.01% 4889

Other funds holding TLSI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WPC
White Pine Capital Bloomington, Minnesota $423M AUM 67.01% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
CWM
Connecticut Wealth Management Farmington, Connecticut $2.7B AUM 21.91% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

PNC Financial Services Group's TLSI Position: Q2 2026 in Review

PNC Financial Services Group increased its TriSalus Life Sciences (TLSI) stake by 309% in Q2 2026, buying an estimated $429 and bringing the position to 143 shares worth $651. The position accounts for ﹤0.01% of the portfolio, ranked #4928.

PNC Financial Services Group first reported a position in TLSI in Q3 2025 and has held it in 4 quarters since. 29 funds tracked by Wall St. Rank hold TLSI as of Q2 2026.

  • PNC Financial Services Group held 143 shares of TriSalus Life Sciences worth $651 as of Q2 2026.
  • PNC Financial Services Group bought 108 TriSalus Life Sciences shares in Q2 2026, an estimated $429.
  • TriSalus Life Sciences made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4928 holding.
  • PNC Financial Services Group first reported a position in TriSalus Life Sciences in Q3 2025 and has held it in 4 quarters since.
  • 29 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.